Posts

Showing posts with the label COVID-19 epidemic gives rise to world's largest vaccine race

ICMR to examine antibodies to corona vaccine given in Patna AIIMS

Image
People involved in the corona vaccine trial in Patna AIIMS  are healthy. Fourteen days after the vaccine, her antibody screening has begun. A sample of 30 such people has been sent to ICMR. A sample of the remaining 20 people will also be sent soon. According to the rules, the sample of these people will be sent again after 28 days of taking the vaccine. After studying these samples, only the ICMR will explain how effective the vaccine was. The vaccine is successful or unsuccessful in the trial. A preferred doctor in the vaccine trial team said that in the first phase, the vaccine can be considered successful in the sense that no side effects were seen in any of the people who were given the vaccine. Neither has anyone been ill in any way. ICMR to examine antibodies to corona vaccine given in Patna AIIMS AIIMS Director Dr. PK Singh said that AIIMS Patna was entrusted with the task of providing vaccines and monitoring them. Under the supervision of Superintendent Dr. CM Singh, a me...

COVID-19 epidemic gives rise to world's largest vaccine race

Image
After the corona epidemic surfaced in the world, China provided the genetic code of the virus in January itself. After this, there was a competition to produce vaccines in many companies and educational institutions. This epidemic has hit almost all the countries of the world. According to data from the World Health Organization (WHO) , more than 160 potential vaccines are in various stages. In such a situation, this epidemic has given rise to the biggest vaccine race in history. COVID-19 epidemic gives rise to world's largest vaccine race That's why work on several vaccines is going on In 2003 SARS spread to more than two dozen countries. More than 8,000 people were infected by it, of which over 770 died. In 2009, the swine flu pandemic spread to more than 200 countries and officially killed about 18,500 people. However many estimates are much more than this. In this epidemic, the vaccine was developed within the first year using a decade old technique. More than 200 countri...